Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 59 (N.D.W.Va. Jan. 8, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 59 (N.D.W.Va. Jan. 8, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 52 (N.D.W.Va. Jan. 4, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 52 (N.D.W.Va. Jan. 4, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 143 (N.D.W.Va. Dec. 6, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 143 (N.D.W.Va. Dec. 6, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 28 (N.D.W.Va. Dec. 8, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 28 (N.D.W.Va. Dec. 8, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 576 (N.D.W.Va. Jul. 7, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 576 (N.D.W.Va. Jul. 7, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 3 (N.D.W.Va. Nov. 9, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 3 (N.D.W.Va. Nov. 9, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 5 (N.D.W.Va. Nov. 9, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 5 (N.D.W.Va. Nov. 9, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 2 (N.D.W.Va. Nov. 9, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 2 (N.D.W.Va. Nov. 9, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 552 (N.D.W.Va. Jun. 22, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 552 (N.D.W.Va. Jun. 22, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 517 (N.D.W.Va. Jun. 2, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 517 (N.D.W.Va. Jun. 2, 2023)
+ More Snippets
Document
IPR2023-00884, No. 62 Motion Other - Motion to Seal (P.T.A.B. Jun. 10, 2024)
Cite Document
IPR2023-00884, No. 62 Motion Other - Motion to Seal (P.T.A.B. Jun. 10, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 486 (N.D.W.Va. May. 23, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 486 (N.D.W.Va. May. 23, 2023)
+ More Snippets
Document
IPR2023-00884, No. 60 Motion Other - Motion for Amended Protective Order (P.T.A.B. May. 31, 2024)
Cite Document
IPR2023-00884, No. 60 Motion Other - Motion for Amended Protective Order (P.T.A.B. May. 31, 2024)
+ More Snippets
Document
IPR2023-00884, No. 57 Opposition - Patent Owner’s Opposition to Petitioner’s Motion for Discovery (P.T.A.B. May. 17, 2024)
Cite Document
IPR2023-00884, No. 57 Opposition - Patent Owner’s Opposition to Petitioner’s Motion for Discovery (P.T.A.B. May. 17, 2024)
+ More Snippets
Document
IPR2023-00884, No. 56 Motion Other - Motion for Discovery Pursuant to 37 CFR § 4251b (P.T.A.B. May. 10, 2024)
Cite Document
IPR2023-00884, No. 56 Motion Other - Motion for Discovery Pursuant to 37 CFR § 4251b (P.T.A.B. May. 10, 2024)
+ More Snippets